Beihai Biotech Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 7

Beihai Biotech General Information

Description

Developer of innovative anti-tumor drugs designed to provide a better life for patients. The company develops new drugs to improve tumor treatments, it committed to developing innovative drugs with unmet clinical needs, enabling cancer patients to improve life quality and treatment effects.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 2, No. 6366, Zhuhai Avenue
  • Jinwan District
  • Zhuhai, Guangdong 519090
  • China
+86 0756
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Building 2, No. 6366, Zhuhai Avenue
  • Jinwan District
  • Zhuhai, Guangdong 519090
  • China
+86 0756

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Beihai Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 14-Dec-2023 Completed Clinical Trials - General
4. Later Stage VC (Series C1) 31-Oct-2022 Completed Clinical Trials - General
3. Later Stage VC (Series A1) 06-Jan-2022 Completed Clinical Trials - Phase 2
2. Later Stage VC (Series A) 01-Jul-2021 $15.6M $15.6M Completed Pre-Clinical Trials
1. Early Stage VC 01-Sep-2017 Completed Pre-Clinical Trials
To view Beihai Biotech’s complete valuation and funding history, request access »

Beihai Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Beihai Biotech Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hunan XiangJiang New Area Development Group PE/Buyout Minority
Oriza FOFs Fund of Funds Minority
Zhuhai International Health Port Government Minority
Yikai Venture Capital Growth/Expansion Minority
Wins Investment Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Beihai Biotech FAQs

  • When was Beihai Biotech founded?

    Beihai Biotech was founded in 2013.

  • Where is Beihai Biotech headquartered?

    Beihai Biotech is headquartered in Zhuhai, China.

  • What is the size of Beihai Biotech?

    Beihai Biotech has 16 total employees.

  • What industry is Beihai Biotech in?

    Beihai Biotech’s primary industry is Drug Discovery.

  • Is Beihai Biotech a private or public company?

    Beihai Biotech is a Private company.

  • What is Beihai Biotech’s current revenue?

    The current revenue for Beihai Biotech is .

  • How much funding has Beihai Biotech raised over time?

    Beihai Biotech has raised $43.4M.

  • Who are Beihai Biotech’s investors?

    Hunan XiangJiang New Area Development Group, Oriza FOFs, Zhuhai International Health Port, Yikai Venture Capital, and Wins Investment are 5 of 7 investors who have invested in Beihai Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process